Table 3.
Classification of MS ligands from datasets A-D according to the cross-validation predictions of the model trained including gene expression (MS(woexp):HPA + MS(wexp):INT) and its associated baseline model trained without this feature (MS(woexp + wexp))
With gene expression (MS(woexp):HPA + MS(wexp):INT) |
||||
---|---|---|---|---|
Strong binder | Weak binder | Non-binder | ||
Without gene expression (MS(woexp + wexp)) | Strong binder |
Conserved Binder (CB) (76.16%) |
Unimproved Binder (UB) (2.57%) |
Lost Binder (LB) (0.02%) |
Weak binder |
Improved Binder (IB) (7.77%) |
Conserved Binder (CB) |
UnClassified peptide (UC) (12.99%) |
|
Non-binder |
Very Improved Binder (VIB) (0.49%) |
UnClassified peptide (UC) | UnClassified peptide (UC) |
The percentile rank score predictions of these two models were employed to classify the ligands. A peptide is considered to be a strong binder if its %rank score is ≤ 0.5, a weak binder if 0.5 < %rank score ≤ 2 and a non-binder if %rank score >2%. The number between parenthesis indicates the % of ligands in each category, e.g. Conserved Binder = 76.16%, UnClassified peptide = 12.99%.